LONDON, May 29 (Reuters) - AstraZeneca's goal of marketing its schizophrenia drug Seroquel XR as a treatment for major depression has been set back by a rejection from Dutch regulators, delaying its ...

LONDON, May 11 (Reuters) - AstraZeneca Plc hopes U.S. approval of a once-daily version of its blockbuster schizophrenia drug Seroquel, expected next week, can break a run of bad product news. The U.S.

Dear Dr. Gott: Please give your opinion on Seroquel being prescribed to a patient with dementia. I've heard it is a dangerous drug when given to the elderly, as it can cause death. Also, should this ...